WHO Collaborating Centre for Reference and Research on Influenza, VIDRL
Surveillance, research, and training activities undertaken at the Centre
WHO: Influenza, an Unpredictable Threat
By the World Health Organisation
The PIP Framework and Partnership Contributions
By the World Health Organisation
The Exciting Journey from Flu Virus to Vaccine (2016)
By the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Lay explanation of influenza surveillance and the processes leading to vaccine production.
Fluorescence-based neuraminidase inhibition assay to assess the susceptibility of influenza viruses to the neuraminidase inhibitor class of antivirals
By the Journal of Visualized Experiments
A description of the neuraminidase inhibition assay as routinely performed at the Centre.
Leang SK and Hurt AC. Fluorescence-based neuraminidase inhibition to assess the susceptibility of influenza viruses to the neuraminidase inhibitor class of antivirals. J Vis Exp, 2017(122).
High Throughput Haemagglutination Analysis using the Tecan Freedom Evo platform
By the WHO Collaborating Centre for Reference and Research on Influenza, Melbourne and SciRobotics
Influenza: Get the (Antigenic) Drift
By the National Institute of Allergy and Infectious Diseases (NIAID)
Information about antigenic drift and influenza vaccines
How Influenza Pandemics Occur
By the National Institute of Allergy and Infectious Diseases (NIAID)
Tracking down the sneeze that started seasonal flu
A description of the evolution and spread of influenza viruses throughout the world, as published in Nature, June 2015, co-authored by Centre staff and international collaborators.
Bedford T, et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift. 2015. Nature 523(7559): 217-220. PubMed link. DOI:10.1038/nature14460